Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Vaccines: an innovative approach to treating cancer.

Pazdur MP, Jones JL.

J Infus Nurs. 2007 May-Jun;30(3):173-8. Review.

PMID:
17505219
2.

Cancer vaccines: a critical review on clinical impact.

Bitton RJ.

Curr Opin Mol Ther. 2004 Feb;6(1):17-26. Review.

PMID:
15011777
3.

Therapeutic cancer vaccines: using unique antigens.

Lewis JJ.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14653-6. Epub 2004 Aug 5. Review.

4.

Recent developments in therapeutic cancer vaccines.

Morse MA, Chui S, Hobeika A, Lyerly HK, Clay T.

Nat Clin Pract Oncol. 2005 Feb;2(2):108-13. Review.

PMID:
16264883
5.

Cancer vaccines entering Phase III clinical trials.

Durrant LG, Spendlove I.

Expert Opin Emerg Drugs. 2003 Nov;8(2):489-500. Review.

PMID:
14662001
6.

Dendritic cell vaccines for cancer therapy.

Sprinzl GM, Kacani L, Schrott-Fischer A, Romani N, Thumfart WF.

Cancer Treat Rev. 2001 Aug;27(4):247-55. Review.

PMID:
11545544
7.

[Peptide-based vaccine therapy for cancer patients].

Yamada A.

Nihon Rinsho. 2005 Apr;63 Suppl 4:602-7. Review. Japanese. No abstract available.

PMID:
15861717
8.

A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.

Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.

Immunol Rev. 2008 Apr;222:316-27. doi: 10.1111/j.1600-065X.2008.00605.x. Review.

PMID:
18364011
9.

Cancer vaccines.

Muehlbauer PM, Schwartzentruber DJ.

Semin Oncol Nurs. 2003 Aug;19(3):206-16. Review.

PMID:
12962010
10.

Clinical results of vaccine therapy for cancer: learning from history for improving the future.

Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H.

Adv Cancer Res. 2006;95:147-202. Review.

PMID:
16860658
11.

Cancer vaccines: between the idea and the reality.

Finn OJ.

Nat Rev Immunol. 2003 Aug;3(8):630-41. Review.

PMID:
12974478
12.

The next generation of vaccines for the treatment of cancer.

Long L, Glover RT, Kaufman HL.

Curr Opin Mol Ther. 1999 Feb;1(1):57-63. Review. No abstract available.

PMID:
11249685
13.

Vaccination and malignant disease: promising therapeutic approach.

McKechnie A, Robins RA, Eremin O.

Surgeon. 2005 Jun;3(3):224-33. Review.

PMID:
16076009
14.

Cancer immunotherapy targeting the telomerase reverse transcriptase.

Huo LF, Tang JW, Huang JJ, Huang PT, Huang CF, Kung HF, Lin MC.

Cell Mol Immunol. 2006 Feb;3(1):1-11. Review.

15.

Custom designing therapeutic cancer vaccines: delivery of immunostimulatory molecule adjuvants by protein transfer.

Selvaraj P, Yerra A, Tien L, Shashidharamurthy R.

Hum Vaccin. 2008 Sep-Oct;4(5):384-8. Epub 2008 Sep 3. Review.

PMID:
18382145
16.

Tumor antigens as surrogate markers and targets for therapy and vaccines.

Dalgleish A, Pandha H.

Adv Cancer Res. 2007;96:175-90. Review.

PMID:
17161680
17.

Novel approaches to therapeutic cancer vaccines.

Hellstrom KE, Hellstrom I.

Expert Rev Vaccines. 2003 Aug;2(4):517-32. Review.

PMID:
14711336
18.

Cancer vaccines.

Bonnefoy JY.

Expert Opin Ther Targets. 2004 Dec;8(6):521-5. Review.

PMID:
15584859
19.

[New advances in clinical trials of cancer vaccines].

Peng F, Wei YQ.

Ai Zheng. 2006 Aug;25(8):1059-62. Review. Chinese.

PMID:
16965694
20.

Cancer vaccine development: on the way to break immune tolerance to malignant cells.

Mocellin S, Rossi CR, Nitti D.

Exp Cell Res. 2004 Oct 1;299(2):267-78. Review.

PMID:
15350526

Supplemental Content

Support Center